Which AML subsets benefit from leukemic cell priming during chemotherapy? Long-term analysis of the ALFA-9802 GM-CSF study-Reference-Cited by-同舟云学术

Which AML subsets benefit from leukemic cell priming during chemotherapy? Long-term analysis of the ALFA-9802 GM-CSF study

Published:2010-04-01 Issue:7 Volume:116 Page:1725-1732
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Thomas Xavier,Raffoux Emmanuel,Renneville Aline,Pautas Cecile,de Botton Stephane,Terre Christine,Gardin Claude,Hayette Sandrine,Preudhomme Claude,Dombret Herve

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.24943/fullpdf

Reference34 articles.

1. Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow;Tanaka;Leuk Res.,1993

2. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation;Te Boekhorst;Leukemia.,1993

3. Modulation of intracellular metabolism in cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor;Reuter;Leukemia.,1994

4. Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA 91 trial);Thomas;Leukemia.,1999

5. Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group;Thomas;Leukemia.,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the Treatment of Senile Acute Myeloid Leukemia;Advances in Clinical Medicine;2023

2. Comparative efficacy and safety of eleven induction chemotherapy regimens for young adult patients with newly diagnosed acute myeloid leukemia: a network meta-analysis;Annals of Hematology;2022-04-20

3. Immunotherapy in AML: a brief review on emerging strategies;Clinical and Translational Oncology;2021-06-23

4. Priming with GM-CSF instead of G-CSF enhances CAG-induced apoptosis of acute monocytic leukemia cells in vitro;Cancer Chemotherapy and Pharmacology;2019-05-21

5. A phase 1 study of chemosensitization with plerixafor plus G-CSF in adults with relapsed acute myeloid leukemia;Leukemia Research;2018-09